Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G27025MB
Summary
- GlyTouCan ID
-
G27025MB
- IUPAC Condensed
- GalNAc(?1-
3D Structures
GlycoShape
Organisms
| Organisms | Evidence |
|---|---|
| Chlorocebus aethiops (grivet) | |
| Homo sapiens (human) | |
| Rhinella arenarum (Argentine toad) | |
| Cricetulus griseus (Chinese hamster) |
Taxonomic Hierarchy
Pathway
| Pathway Name | Organism |
|---|---|
| CS/DS degradation | Mus musculus |
| Glycosphingolipid catabolism | Canis familiaris |
| Glycosphingolipid catabolism | Xenopus tropicalis |
| Glycosphingolipid catabolism | Caenorhabditis elegans |
| Glycosphingolipid catabolism | Bos taurus |
| Glycosphingolipid catabolism | Dictyostelium discoideum |
| Glycosphingolipid catabolism | Gallus gallus |
| Glycosphingolipid catabolism | Homo sapiens |
| Glycosphingolipid catabolism | Rattus norvegicus |
| Glycosphingolipid catabolism | Drosophila melanogaster |
Sequence Descriptors
- GlycoCT
-
RES 1b:x-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
- WURCS
- WURCS=2.0/1,1,0/[a2112h-1x_1-5_2*NCC/3=O]/1/
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 39343861 | Biochemical Amenability in Fabry Patients Under Chaperone Therapy—How and When to Test? | Lenders M | 2024 Sep 30 |
|
| 39347913 | Beyond the Guidelines: Perspectives on Management of Pediatric Patients with Hypertriglyceridemia | Gagnon CA | 2024 Sep 30 |
|
| 39294369 | Genomics 2 Proteins portal: a resource and discovery tool for linking genetic screening outputs to protein sequences and structures | Kwon S | 2024 Sep 18 |
|
| 38839445 | Personalized dosage of Givosiran in acute intermittent porphyria | Garrido Montes M | 2024 Sep 13 |
|
| 39266802 | Design of Auto-Adaptive Drug Delivery System for Effective Delivery of Peptide Drugs to Overcoming Mucus and Epithelial Barriers | Ding R | 2024 Sep 12 |
|
| 39249571 | Strategies for producing probiotic biomass and postbiotics from Akkermansia muciniphila in submerged cultivations incorporating prebiotic sources | Montipó S | 2024 Sep 09 |
|
| 39245709 | GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+ T cells | Sun X | 2024 Sep 08 |
|
| 39237967 | GALNT9 enrichment attenuates MPP+-induced cytotoxicity by ameliorating protein aggregations containing α-synuclein and mitochondrial dysfunction | Peng Y | 2024 Sep 05 |
|
| 39232672 | Role of the GalNAc-galectin pathway in the healing of premature rupture of membranes | Chen JL | 2024 Sep 04 |
|
| 39232245 | The pathogenesis of IgA nephropathy and implications for treatment | Cheung CK | 2024 Sep 04 |
|
